Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction | MicrobiomeTrials← Back to trialsNCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-09-02Est. Completion: 2026-09-30
Enrollment target: 40 participants Other microbiome trials you might be interested in
Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
The goal of this clinical trial is to learn if an herbal supplement called Biocidin REMOVE can clear small intestinal ba…
Baltimore, United StatesEst. completion Dec 31, 2027
Food Intolerance SyndromesSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Breath Tests
Hydrogen (H₂) breath tests serve several purposes. (i) detect malabsorption of carbohydrates such as lactose and fructos…
Arlesheim, SwitzerlandCompleted Dec 31, 2025
Eosinophilic EsophagitisGastroesophageal Reflux Disease (GERD)GastroparesisFunctional VomitingIrritable Bowel Syndrome (IBS)ConstipationChronic Intestinal Pseudo-obstructionFecal IncontinenceSmall Intestinal Bacterial Overgrowth
Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to …
Indianapolis, United StatesEst. completion Nov 2026